Dr. Chipps is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5609 J St
Ste C
Sacramento, CA 95819Phone+1 916-453-8696Fax+1 916-453-8715
Education & Training
- Johns Hopkins UniversityFellowship, Allergy and Immunology, 1977 - 1978
- Johns Hopkins UniversityResidency, Pediatrics, 1976 - 1977
- University of Texas Medical Branch HospitalsResidency, Pediatrics, 1972 - 1974
- University of Texas Medical Branch School of MedicineClass of 1972
Certifications & Licensure
- CA State Medical License 1979 - 2026
- TX State Medical License 1972 - 1991
- MD State Medical License 1976 - 1982
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
- Join now to see all
Publications & Presentations
PubMed
- 21 citationsBenefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristicsMark C. Liu, Bradley E. Chipps, Xavier Muñoz, Gilles Devouassoux, Miguel Bergna
Respiratory Research. 2021-05-10 - 832 citationsStandards and indications for cardiopulmonary sleep studies in childrenGerald M. Loughlin, Robert T. Brouillette, L. J. Brooke, John L. Carroll, B. E. Chipps
American Journal of Respiratory and Critical Care Medicine. 1996-01-01 - 65 citationsDupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma.Jonathan Corren, Mario Castro, Thomas G. O'Riordan, Nicola A. Hanania, Ian D. Pavord
The Journal of Allergy and Clinical Immunology. in Practice. 2020-02-01
Press Mentions
- What Is the Optimal Reliever Therapy for Difficult-to-Control Asthma?October 28th, 2024
- Many Severe Asthma Patients Achieve Remission on BiologicsFebruary 28th, 2022
- Don’t Overlook the EyesFebruary 20th, 2020
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: